Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03045250

Corneal Confocal Microscopy in Patients With Type 1 Diabetes

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Albert Einstein College of Medicine · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Assessing the use of corneal confocal microscopy to evaluate for early neuropathy changes in subjects with Type 1 Diabetes.

Detailed description

Rationale: Poorly controlled diabetes mellitus is associated with microvascular complications, which includes peripheral neuropathy. Peripheral neuropathy associated with diabetes is a painful condition. Its diagnosis is hampered by painful and long nerve conduction studies which fail to diagnose small nerve neuropathy. It is important to study methods of noninvasive methods of early detection, which are sensitive and specific in diagnosing early neuropathy and we propose a novel study that this can be detected in the cornea of the eye. Aims: * Estimate corneal small nerve fiber damage in young T1DM subjects (corneal fiber density, nerve branch density, and fiber length) and compare the results to healthy controls using corneal confocal microscopy (CCM). * Estimate corneal nerve fiber damage in subjects with diabetes, with peripheral neuropathy and subjects with diabetes without peripheral neuropathy, diagnosed by skin biopsies and nerve conduction studies * Obtain much needed normative values for CCM in adolescents and intraepidermal nerve fiber density from skin biopsies in subjects with type 1 diabetes. * As a secondary outcome measure, to compare serum biomarkers including leptin, TNF alpha, and fibrinogen in patients with diabetes in those with neuropathy Vs. without neuropathy.

Conditions

Interventions

TypeNameDescription
DEVICECorneal confocal microscopyConfocal miscroscopy will be used to assess corneal nerve changes due to hyperglycemia.
PROCEDURESkin biopsySkin biopsy will be used to assess the appearance of nerve fibers in subjects with type 1 diabetes.
PROCEDURENerve conduction studyNerve conduction studies will be use to assess for neuropathy.
OTHERBlood drawSubjects will undergo a one time blood draw for biomarkers.

Timeline

Start date
2018-08-01
Primary completion
2020-02-01
Completion
2020-02-01
First posted
2017-02-07
Last updated
2018-09-04

Source: ClinicalTrials.gov record NCT03045250. Inclusion in this directory is not an endorsement.